Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
Treatment Resistant Cancers
Cancer
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 13, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Zi-Rui Ren1, Lv Wu1, Chang Lu1
1Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Targeted therapy is limited in multiple primary lung cancers (MPLCs) due to molecular differences. Chemoimmunotherapy effectively treated heterogeneous MPLC lesions, enabling surgery but early recurrence highlighted unmet needs.
Area of Science:
Background: